ES2910034T3 - Procedimiento de fototerapia dinámica (FTD) para el cáncer de vejiga - Google Patents

Procedimiento de fototerapia dinámica (FTD) para el cáncer de vejiga Download PDF

Info

Publication number
ES2910034T3
ES2910034T3 ES16810437T ES16810437T ES2910034T3 ES 2910034 T3 ES2910034 T3 ES 2910034T3 ES 16810437 T ES16810437 T ES 16810437T ES 16810437 T ES16810437 T ES 16810437T ES 2910034 T3 ES2910034 T3 ES 2910034T3
Authority
ES
Spain
Prior art keywords
light
bladder
composition
blue light
hal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES16810437T
Other languages
English (en)
Spanish (es)
Inventor
Kjetil Hestdal
Aslak Godal
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Photocure ASA
Original Assignee
Photocure ASA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Photocure ASA filed Critical Photocure ASA
Application granted granted Critical
Publication of ES2910034T3 publication Critical patent/ES2910034T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0613—Apparatus adapted for a specific treatment
    • A61N5/062—Photodynamic therapy, i.e. excitation of an agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B1/00—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
    • A61B1/307—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor for the urinary organs, e.g. urethroscopes or cystoscopes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0061—5-aminolevulinic acid-based PDT: 5-ALA-PDT involving porphyrins or precursors of protoporphyrins generated in vivo from 5-ALA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0601—Apparatus for use inside the body
    • A61N5/0603—Apparatus for use inside the body for treatment of body cavities
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0601—Apparatus for use inside the body
    • A61N5/0603—Apparatus for use inside the body for treatment of body cavities
    • A61N2005/061—Bladder and/or urethra
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
    • A61N2005/0662—Visible light
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
    • A61N2005/0662—Visible light
    • A61N2005/0663—Coloured light

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Pathology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Medical Informatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Optics & Photonics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Radiation-Therapy Devices (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
ES16810437T 2015-12-17 2016-12-19 Procedimiento de fototerapia dinámica (FTD) para el cáncer de vejiga Active ES2910034T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP15200938 2015-12-17
PCT/EP2016/081809 WO2017103285A1 (en) 2015-12-17 2016-12-19 Method of photodynamic therapy (pdt) for bladder cancer

Publications (1)

Publication Number Publication Date
ES2910034T3 true ES2910034T3 (es) 2022-05-11

Family

ID=55066354

Family Applications (1)

Application Number Title Priority Date Filing Date
ES16810437T Active ES2910034T3 (es) 2015-12-17 2016-12-19 Procedimiento de fototerapia dinámica (FTD) para el cáncer de vejiga

Country Status (18)

Country Link
US (2) US11235168B2 (enExample)
EP (1) EP3389716B1 (enExample)
JP (1) JP6995755B2 (enExample)
KR (1) KR102787192B1 (enExample)
CN (2) CN119345612A (enExample)
AU (1) AU2016372575B2 (enExample)
BR (1) BR112018011965A2 (enExample)
CA (1) CA3008552C (enExample)
CL (1) CL2018001612A1 (enExample)
DK (1) DK3389716T3 (enExample)
ES (1) ES2910034T3 (enExample)
IL (1) IL259925B (enExample)
MX (1) MX385912B (enExample)
PL (1) PL3389716T3 (enExample)
RU (1) RU2745194C2 (enExample)
SG (1) SG11201805000RA (enExample)
WO (1) WO2017103285A1 (enExample)
ZA (1) ZA201804530B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3389716B1 (en) * 2015-12-17 2022-03-23 Photocure ASA Method of photodynamic therapy (pdt) for bladder cancer
CN110420326A (zh) * 2019-09-17 2019-11-08 上海复旦张江生物医药股份有限公司 一种多替泊芬的应用
KR20240011794A (ko) * 2021-08-17 2024-01-26 보스톤 싸이엔티픽 싸이메드 인코포레이티드 광활성제의 활성화를 위한 디바이스, 시스템 및 방법
KR20250154511A (ko) 2023-03-07 2025-10-28 포토큐어 에이에스에이 방광암 치료
WO2026052815A1 (en) 2024-09-05 2026-03-12 Photocure Asa Use of hal in a method for predicting bladder cancer immunotherapy response

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE122006000051I1 (de) 1995-03-10 2007-01-04 Photocure Asa Ester der 5-Aminolevulins{ure als Mittel zur Photosensibillisierung in der Chemotherapie
US7530461B2 (en) * 1995-03-10 2009-05-12 Photocure Asa Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy
US20050003154A1 (en) * 2002-12-13 2005-01-06 White Gary L. Laminated building panels having preselected colors
GB0406917D0 (en) 2004-03-26 2004-04-28 Photocure Asa Compounds
GB0700580D0 (en) 2007-01-11 2007-02-21 Photocure Asa Use
GB0724279D0 (en) 2007-12-12 2008-01-23 Photocure Asa Use
CN101891639A (zh) 2009-05-20 2010-11-24 上海先导化学有限公司 一种制备5-氨基酮戊酸盐酸盐的方法
AU2010257752B2 (en) 2009-06-11 2015-04-09 Photocure Asa Solid compositions comprising 5-aminolevulinic acid
WO2010142457A1 (en) 2009-06-11 2010-12-16 Photocure Asa Semi-solid compositions and pharmaceutical products
RU2448745C2 (ru) * 2010-05-31 2012-04-27 Олег Феликсович Каган Способ лечения поверхностного рака мочевого пузыря
US20150088001A1 (en) 2011-12-19 2015-03-26 Technical University Of Denmark Illumination System for Endoscopic Applications
RU2635563C2 (ru) * 2012-08-03 2017-11-14 ФотоКьюэр АСА Соединения
GB201221123D0 (en) * 2012-11-23 2013-01-09 Photocure As Device for photodynamic treatment
EP3389716B1 (en) * 2015-12-17 2022-03-23 Photocure ASA Method of photodynamic therapy (pdt) for bladder cancer

Also Published As

Publication number Publication date
US11235168B2 (en) 2022-02-01
CL2018001612A1 (es) 2019-01-11
RU2745194C2 (ru) 2021-03-22
AU2016372575A1 (en) 2018-07-12
CA3008552A1 (en) 2017-06-22
DK3389716T3 (da) 2022-04-11
MX385912B (es) 2025-03-18
IL259925A (en) 2018-07-31
CN119345612A (zh) 2025-01-24
KR102787192B1 (ko) 2025-03-25
KR20180094986A (ko) 2018-08-24
PL3389716T3 (pl) 2022-06-20
AU2016372575B2 (en) 2022-12-08
EP3389716A1 (en) 2018-10-24
JP2019501161A (ja) 2019-01-17
NZ743697A (en) 2024-10-25
ZA201804530B (en) 2019-09-25
EP3389716B1 (en) 2022-03-23
RU2018123834A3 (enExample) 2020-04-13
US11980772B2 (en) 2024-05-14
JP6995755B2 (ja) 2022-01-17
SG11201805000RA (en) 2018-07-30
BR112018011965A2 (pt) 2018-12-04
US20220152411A1 (en) 2022-05-19
RU2018123834A (ru) 2020-01-17
CA3008552C (en) 2024-01-02
WO2017103285A1 (en) 2017-06-22
US20190022404A1 (en) 2019-01-24
CN108697800A (zh) 2018-10-23
IL259925B (en) 2022-04-01

Similar Documents

Publication Publication Date Title
US11980772B2 (en) Method of photodynamic therapy (PDT) for bladder cancer
ES3015668T3 (en) Neoadjuvant therapy for bladder cancer
US11066478B2 (en) Intravesical therapy for bladder cancer
HK1262650A1 (en) Method of photodynamic therapy (pdt) for bladder cancer
JP2002538201A (ja) 癌を診断および治療する手段
RU2783177C2 (ru) Неоадъювантная терапия для рака мочевого пузыря
CA3008551C (en) Neoadjuvant therapy for bladder cancer
CA3008548C (en) Intravesical therapy for bladder cancer
BR112018012116B1 (pt) Uso de anticorpos anti-pd-l1 e/ou anticorpos anti-pd-1 e éster hexílico de 5-ala ou um sal farmaceuticamente aceitável do mesmo
KR20250154511A (ko) 방광암 치료